Matthew Schneier

features writer for New York Magazine and The Cut covering culture, style, and the city

Matthew Schneier on KCRW

The drug Ozempic has become an appetite suppressant for some rich and well-connected people. It's changing the definition of thinness and what it takes to achieve it.

Latest weight-loss craze is a drug for diabetics — Ozempic

The drug Ozempic has become an appetite suppressant for some rich and well-connected people. It's changing the definition of thinness and what it takes to achieve it.

from Press Play with Madeleine Brand

More from KCRW

Nature, the great outdoors, and our interdependence.

from Life Examined

When one in three people have an abnormal lab test, does it become a disease?

from Second Opinion

KCRW unravels a disruptive White House week. Is the president just stirring outrage? Plus, we discuss Elon Musk’s influence on the foreign aid fight.

from Left, Right & Center

Fast food workers lose about 16% of their pay every year, a new Northwestern University study found.

from KCRW Features

Donald Trump has never won Orange County, but new Republican leadership hopes to turn a purple region into a GOP stronghold.

from KCRW Features

The cleanup is underway in Altadena and Pacific Palisades, and local organizations are educating immigrant day laborers on how to stay safe.

from KCRW Features

Hopefully, we’ve learned many lessons, but there is still lots to be learned.

from Second Opinion

By collecting health data across large populations of people, we can identify patterns that help us all.

from Second Opinion

KCRW and R&S Kayne Foundation Los Angeles held a public information panel and Q&A session regarding immediate and long-term health considerations from the fires.

from KCRW Features